Published in Immunology on January 01, 1994
Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J Exp Med (1996) 1.50
Gamma delta T cells from tolerized alpha beta T cell receptor (TCR)-deficient mice inhibit contact sensitivity-effector T cells in vivo, and their interferon-gamma production in vitro. J Exp Med (1996) 0.94
Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications. Liver Int (2015) 0.86
A subset of gamma delta T-cell receptor-positive cells produce T-helper type-2 cytokines and regulate mouse skin graft rejection following portal venous pretransplant preimmunization. Immunology (1996) 0.83
CpG oligodeoxynucleotide triggers the liver inflammatory reaction and abrogates spontaneous tolerance. Liver Transpl (2009) 0.81
γδ T cells augment rejection of skin grafts by enhancing cross-priming of CD8 T cells to skin-derived antigen. J Invest Dermatol (2012) 0.79
Acceptance of skin allografts in pigs by portal venous injection of donor bone marrow cells. Ann Surg (1999) 0.75
T cell tolerance by clonal elimination in the thymus. Cell (1987) 13.83
Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol (1991) 11.04
Separation of cells by velocity sedimentation. J Cell Physiol (1969) 8.73
Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol (1989) 7.69
Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol (1988) 6.51
Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med (1987) 5.48
Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med (1993) 4.09
Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science (1992) 2.43
Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature (1992) 1.92
Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen. J Exp Med (1993) 1.69
Acquired immunological tolerance of foreign cells is impaired by recombinant interleukin 2 or vitamin A acetate. Proc Natl Acad Sci U S A (1985) 1.53
Speculations on the specificity of suppression. Immunol Today (1989) 1.43
Subsets of CD4+ T cells and their roles in the induction and prevention of autoimmunity. Immunol Rev (1991) 1.36
Neonatal tolerance induction by class II alloantigens activates IL-4-secreting, tolerogen-responsive T cells. J Immunol (1990) 1.23
Characterization of gamma delta T lymphocytes at the maternal-fetal interface. J Immunol (1992) 1.11
A transgenic approach to the study of peripheral T-cell tolerance. Immunol Rev (1991) 1.03
Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type-hypersensitivity response to alloantigens by portal venous inoculation with allogeneic cells. J Immunol (1985) 0.94
Immunosuppression induced by hepatic portal venous immunization spares reactivity in IL-4 producing T lymphocytes. Immunol Lett (1992) 0.93
Specific manipulation in vivo of immunity to skin grafts bearing multiple minor histocompatibility differences. Immunol Lett (1991) 0.84
Differential sensitivity to anti-LFA-1 inhibition of Th1 vs Th2 anti-minor histocompatibility antigen immune T cells after restimulation with antigen on hepatic or splenic APCs. Transplant Proc (1993) 0.81
Tolerance to host minor histocompatibility antigens after allogenic bone marrow transplantation. Specific donor-host unresponsiveness is maintained by peripheral tolerizing cells. J Immunol (1992) 0.80
Antigen presentation by murine splenic, but not hepatic, antigen-presenting cells to induce IL-2/IL-4 production from immune T cells is regulated by interactions between LFA-1/ICAM-1. Immunol Lett (1992) 0.80
Prolongation of rat small bowel or renal allograft survival by pretransplant transfusion and/or by varying the route of allograft venous drainage. Transplantation (1994) 0.95
Regulation of IFN-gamma and IL-10 synthesis in vivo, as well as continuous antigen exposure, is associated with tolerance to murine skin allografts. Cell Immunol (1995) 0.86
A subset of gamma delta T-cell receptor-positive cells produce T-helper type-2 cytokines and regulate mouse skin graft rejection following portal venous pretransplant preimmunization. Immunology (1996) 0.83
Conditioned enhancement of skin allografts in mice. Brain Behav Immun (1990) 0.81
Differential sensitivity to anti-LFA-1 inhibition of Th1 vs Th2 anti-minor histocompatibility antigen immune T cells after restimulation with antigen on hepatic or splenic APCs. Transplant Proc (1993) 0.81
Tolerance induction to multiple minor histoincompatible cells by activated B cells is associated with preferential activation of Th2 cells. Transplantation (1994) 0.80
Antigen presentation by murine splenic, but not hepatic, antigen-presenting cells to induce IL-2/IL-4 production from immune T cells is regulated by interactions between LFA-1/ICAM-1. Immunol Lett (1992) 0.80
Conditioned stress responses by pregnant and/or lactating mice reduce immune responses of their offspring after weaning. Brain Behav Immun (1992) 0.79
Antigenic variation in Leishmania mexicana following infection of immunized mice leads to relative sparing of suppressor determinants. Immunol Lett (1990) 0.79
Functional activity in host and graft lymphoid tissue of rats receiving syngeneic heterotopic small bowel transplants with portal or systemic drainage. Immunol Lett (1993) 0.75
A fetal sheep liver extract reverses age-related increments in spontaneous and induced cytokine production by indirect environmental effects. Immunol Lett (1998) 0.75
Hepatic regulation of lymphocyte-endothelial cell interaction. Transplant Proc (1994) 0.75
Neuroleptic and anti-depressant drug treatment abolishes conditioned immunosuppression in mice. Brain Behav Immun (1989) 0.75